Announcement under Regulation 30 (LODR)-Newspaper Publication
Filed with BSE · · 3 pages · English
Summary by 6ix AI
This filing is made in compliance with SEBI regulations concerning disclosure requirements. The document includes a reference to the company's registration details and contact information.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 30 2026
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 23 2026
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 03 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Welcure Drugs and Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday, 19Th June, 2026
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 19 2026
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday, 14Th July, 2026.
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jul 14 2026
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals